Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment

Background: People with multiple sclerosis ‎(MS) and their physicians recognize cognitive retention as an important desired outcome of disease-modifying therapies (DMTs). In this study, we attempted to gather the opinions of Iranian MS experts regarding the treatment approach toward clinical cases w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadiri, Fereshteh, Asadollahzadeh, Elnaz, Ebadi, Zahra, Sahraian, Mohammad Ali, Azimi, Amirreza, Navardi, Samira, Heidari, Hora, Abna, Zohreh, Aboutorabi, Marzieh, Adibi, Iman, Baghbanian, Seyed Mohammad, Paybast, Sepideh, Poursadeghfard, Maryam, Hosseini, Samaneh, Shahmohammadi, Sareh, Ghaffari, Mehran, Ghalyanchi-Langroodi, Hamidreza, Ghiasian, Masoud, Kamali, Hoda, Kouchaki, Ebrahim, Mahrabi, Farzad, Mohammadianinejad, Ehsan, Nahayati, Mohammad Ali, Moghadasi, Abdorreza Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444593/
https://www.ncbi.nlm.nih.gov/pubmed/38011357
http://dx.doi.org/10.18502/cjn.v22i1.12610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444593/
https://www.ncbi.nlm.nih.gov/pubmed/38011357
http://dx.doi.org/10.18502/cjn.v22i1.12610

Ejemplares similares